Literature DB >> 29853480

A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine.

Taraneh Taghavi1,2, Maria Novalen1,2, Caryn Lerman3, Tony P George1,4, Rachel F Tyndale5,2,4.   

Abstract

Background: Total nicotine equivalents (TNE), the sum of nicotine and metabolites in urine, is a valuable tool for evaluating nicotine exposure. Most methods for measuring TNE involve two-step enzymatic hydrolysis for indirect quantification of glucuronide metabolites. Here, we describe a rapid, low-cost direct LC/MS assay.
Methods: In 139 smokers' urine samples, Bland-Altman, correlation, and regression analyses were used to investigate differences in quantification of nicotine and metabolites, TNE, and nicotine metabolite ratio (NMR) between direct and indirect LC/MS methods. DNA from a subset (n = 97 smokers) was genotyped for UGT2B10*2 and UGT2B17*2, and the known impact of these variants was evaluated using urinary ratios determined by the direct versus indirect method.
Results: The direct method showed high accuracy (0%-9% bias) and precision (3%-14% coefficient of variation) with similar distribution of nicotine metabolites to literary estimates and good agreement between the direct and indirect methods for nicotine, cotinine, and 3-hydroxycotinine (ratios 0.99-1.07), but less agreement for their respective glucuronides (ratios 1.16-4.17). The direct method identified urinary 3HC+3HC-GLUC/COT as having the highest concordance with plasma NMR and provided substantially better estimations of the established genetic impact of glucuronidation variants compared with the indirect method.Conclusions: Direct quantification of nicotine and metabolites is less time-consuming and less costly, and provides accurate estimates of nicotine intake, metabolism rate, and the impact of genetic variation in smokers.Impact: Lower cost and maintenance combined with high accuracy and reproducibility make the direct method ideal for smoking biomarker, NMR, and pharmacogenomics studies. Cancer Epidemiol Biomarkers Prev; 27(8); 882-91. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29853480      PMCID: PMC6072604          DOI: 10.1158/1055-9965.EPI-18-0018

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  49 in total

1.  Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.

Authors:  Delia Dempsey; Piotr Tutka; Peyton Jacob; Faith Allen; Kerri Schoedel; Rachel F Tyndale; Neal L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2004-07       Impact factor: 6.875

2.  Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.

Authors:  F Patterson; R A Schnoll; E P Wileyto; A Pinto; L H Epstein; P G Shields; L W Hawk; R F Tyndale; N Benowitz; C Lerman
Journal:  Clin Pharmacol Ther       Date:  2008-04-02       Impact factor: 6.875

3.  Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.

Authors:  S S Hecht; S G Carmella; M Chen; J F Dor Koch; A T Miller; S E Murphy; J A Jensen; C L Zimmerman; D K Hatsukami
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

4.  Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.

Authors:  Caryn Lerman; Robert A Schnoll; Larry W Hawk; Paul Cinciripini; Tony P George; E Paul Wileyto; Gary E Swan; Neal L Benowitz; Daniel F Heitjan; Rachel F Tyndale
Journal:  Lancet Respir Med       Date:  2015-01-12       Impact factor: 30.700

5.  Trans-3'-hydroxycotinine as a main metabolite in urine of smokers.

Authors:  G B Neurath; M Dünger; D Orth; F G Pein
Journal:  Int Arch Occup Environ Health       Date:  1987       Impact factor: 3.015

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  Is 24h nicotine equivalents a surrogate for smoke exposure based on its relationship with other biomarkers of exposure?

Authors:  Jingzhu Wang; Qiwei Liang; Paul Mendes; Mohamadi Sarkar
Journal:  Biomarkers       Date:  2011-03       Impact factor: 2.658

8.  N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases.

Authors:  Gwendolyn E Kuehl; Sharon E Murphy
Journal:  Drug Metab Dispos       Date:  2003-11       Impact factor: 3.922

9.  Determination of the nicotine metabolite trans-3'-hydroxycotinine in urine of smokers using gas chromatography with nitrogen-selective detection or selected ion monitoring.

Authors:  P Jacob; A T Shulgin; L Yu; N L Benowitz
Journal:  J Chromatogr       Date:  1992-12-02

Review 10.  Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes.

Authors:  Riju Ray; Rachel F Tyndale; Caryn Lerman
Journal:  J Neurogenet       Date:  2009-01-23       Impact factor: 1.250

View more
  6 in total

1.  Cigarette consumption and biomarkers of nicotine exposure during pregnancy and postpartum.

Authors:  Taraneh Taghavi; Christopher A Arger; Sarah H Heil; Stephen T Higgins; Rachel F Tyndale
Journal:  Addiction       Date:  2018-07-23       Impact factor: 6.526

2.  Pregnancy-Induced Increases in the Nicotine Metabolite Ratio: Examining Changes During Antepartum and Postpartum.

Authors:  Christopher A Arger; Taraneh Taghavi; Sarah H Heil; Joan Skelly; Rachel F Tyndale; Stephen T Higgins
Journal:  Nicotine Tob Res       Date:  2019-11-19       Impact factor: 4.244

3.  Nicotine Exposure by Device Type among Adult Electronic Nicotine Delivery System Users in the Population Assessment of Tobacco and Health Study, 2015-2016.

Authors:  Brian L Rostron; Blair Coleman; Yu-Ching Cheng; Heather L Kimmel; Olusola Oniyide; Lanqing Wang; Cindy M Chang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-29       Impact factor: 4.254

4.  Nicotine metabolite ratio: Comparison of the three urinary versions to the plasma version and nicotine clearance in three clinical studies.

Authors:  Haidy K Giratallah; Meghan J Chenoweth; Newton Addo; Jasjit S Ahluwalia; Lisa Sanderson Cox; Caryn Lerman; Tony P George; Neal L Benowitz; Rachel F Tyndale
Journal:  Drug Alcohol Depend       Date:  2021-04-20       Impact factor: 4.852

5.  Application of HPLC-QQQ-MS/MS and New RP-HPLC-DAD System Utilizing the Chaotropic Effect for Determination of Nicotine and Its Major Metabolites Cotinine, and trans-3'-Hydroxycotinine in Human Plasma Samples.

Authors:  Jacek Baj; Wojciech Flieger; Dominika Przygodzka; Grzegorz Buszewicz; Grzegorz Teresiński; Magdalena Pizoń; Ryszard Maciejewski; Jolanta Flieger
Journal:  Molecules       Date:  2022-01-20       Impact factor: 4.411

6.  Predicting nicotine metabolism across ancestries using genotypes.

Authors:  James W Baurley; Andrew W Bergen; Carolyn M Ervin; Sung-Shim Lani Park; Sharon E Murphy; Christopher S McMahan
Journal:  BMC Genomics       Date:  2022-09-21       Impact factor: 4.547

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.